Kuan-Hsun Lin

Kuan-Hsun Lin

Auto-generated profile, based on publicly available information

Kuan-Hsun Lin

Department of Information Management, Taipei Veterans General Hospital, No 201, Sec 2, Shipai Rd, Beitou District, Taipei, 11217, Taiwan, +886 986-680623, 886 2-28757841

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 August 2025 in Clinical Kidney Journal
Verified
Journal Article
Open access
TCTz-Heng Chen
Tz-Heng Chen
Shuo-Ming OuShuo-Ming Ou
Shuo-Ming Ou
KLKuan-Hsun Lin
Kuan-Hsun Lin
YHYang Ho
Yang Ho
WTWei-Cheng Tseng
Wei-Cheng Tseng
DTDer-Cherng Tarng
Der-Cherng Tarng
Background: Steroidal mineralocorticoid receptor antagonists (MRAs), including spironolactone, effectively treat resistant hypertension, reduce proteinuria and lower mortality in heart failure with reduced ejection fraction. However, their long-term effects in chronic kidney disease (CKD) remain unclear. This study investigated spironolactone's impact on end-stage renal disease (ESRD), major adverse cardiovascular events (MACE), hyperkalemia and mortality in CKD patients. Methods: This retrospective hospital-based cohort study enrolled patients with CKD stage 3–5 between 1 January 2011 and 30 June 2023. The patients were classified as spironolactone users or nonusers, with each user matched to two nonusers by propensity scores. The outcomes of interest included ESRD, MACE, all-cause mortality and severe hyperkalemia. MACE include nonfatal stroke, nonfatal myocardial infarction and cardiovascular death. Results: After propensity score matching, 2711 spironolactone users and 5422 nonusers were included in this analysis. Spironolactone users exhibited higher risks of all-cause mortality [adjusted hazard ratio (aHR) 1.23; 95% confidence interval (CI) 1.11–1.37] and severe hyperkalemia (aHR 1.44; 95% CI 1.24–1.68) than nonusers. However, there was a lower risk of MACE (aHR 0.90; 95% CI 0.82–0.99), primarily due to a significant reduction in stroke risk (aHR 0.79; 95% CI 0.71–0.88). The risk of ESRD was similar between the two groups (aHR 1.09; 95% CI 0.85–1.38). Conclusions: In patients with CKD, spironolactone use was associated with a decreased risk of stroke but increased risks of severe hyperkalemia and all-cause mortality, while the risk of ESRD remained unchanged. Individualized clinical decision-making and appropriate dose adjustment are important to balance the potential benefits and risks associated with spironolactone therapy.

1 May 2025 in Digital Health
Verified
Journal Article
Open access
YCYuan-Chia Chu
Yuan-Chia Chu
YCYen-Chi Chen
Yen-Chi Chen
CHChien-Yeh Hsu
Chien-Yeh Hsu
CKChen-Tsung Kuo
Chen-Tsung Kuo
YCYen-Fu Cheng
Yen-Fu Cheng
WLWen Huei Liao
Wen Huei Liao
Background: Otitis media remains a significant global health concern, particularly in resource-limited settings where timely diagnosis is challenging. Artificial intelligence (AI) offers promising solutions to enhance diagnostic accuracy in mobile health applications. Objective: This study introduces a hybrid AI framework that integrates convolutional neural networks (CNNs) for image classification with large language models (LLMs) for clinical reasoning, enabling real-time otoscopic diagnosis. Methods: We developed a dual-path system combining CNN-based feature extraction with LLM-supported interpretation. The framework was optimized for mobile deployment, with lightweight models operating on-device and advanced reasoning performed via secure cloud APIs. A dataset of 10,465 otoendoscopic images (expanded from 2820 original clinical images through data augmentation) across 10 middle-ear conditions was used for training and validation. Diagnostic performance was benchmarked against clinicians of varying expertise. Results: The hybrid CNN–LLM system achieved an overall diagnostic accuracy of 97.6%, demonstrating the synergistic benefit of combining CNN-driven visual analysis with LLM-based clinical reasoning. The system delivered sub-200 ms feedback and achieved specialist-level performance in identifying common ear pathologies. Conclusions: This hybrid AI framework substantially improves diagnostic precision and responsiveness in otoscopic evaluation. Its mobile-friendly design supports scalable deployment in telemedicine and primary care, offering a practical solution to enhance ear disease diagnosis in underserved regions.

13 May 2026 in JMIR Formative Research
Verified
Journal Article
Open access
KLKuan-Hsun Lin
Kuan-Hsun Lin
CCChia-Ping Chang
Chia-Ping Chang
CKChen-Tsung Kuo
Chen-Tsung Kuo
Chien-Yeh HsuChien-Yeh Hsu
Chien-Yeh Hsu
SHShih-Hsin Hung
Shih-Hsin Hung
YCYuan-chia Chu
Yuan-chia Chu
Background: Accurate transcription of pathology gross examination dictation is important for clinical documentation, but multilingual dictation remains challenging in settings where clinicians mix Chinese and English while final pathology reports are written in English. Objective: This study aimed to evaluate whether a Whisper-based automatic speech recognition (ASR) pipeline guided by contextual system messages and combined with open-source large language models (LLMs; Qwen2:72b, Llama3.1:70b, Gemma2:27b) could improve multilingual (Chinese-English) pathology dictation transcription accuracy and generate clinically appropriate English gross description reports. Methods: We conducted a controlled proof-of-concept study using 125 simulated mixed Chinese-English pathology gross examination audio recordings created by physicians or pathologists. Audio recordings were transcribed using Whisper ASR with and without a contextual system message. The ASR transcripts were then converted into English gross description reports using 3 open-source LLMs: Qwen2:72b, Llama3.1:70b, and Gemma2:27b. Outcomes included character error rate, Bilingual Evaluation Understudy, Recall-Oriented Understudy for Gisting Evaluation (ROUGE)-1, ROUGE-2, ROUGE-L, Metric for Evaluation of Translation with Explicit Ordering, pathologist Win-Tie-Lose rankings, report-level error categories, inference time, and interrater agreement. Results: The ASR contextual system message reduced the mean character error rate from 0.344 (SD 0.176; 95% CI 0.313‐0.375) to 0.066 (SD 0.100; 95% CI 0.048‐0.084; P <.001). Qwen2:72b achieved the highest automated metric scores, including a Bilingual Evaluation Understudy of 0.644 (SD 0.307), ROUGE-1 of 0.866 (SD 0.163), ROUGE-2 of 0.771 (SD 0.235), ROUGE-L of 0.842 (SD 0.178), and Metric for Evaluation of Translation with Explicit Ordering of 0.805 (SD 0.214). Pathologist-coded total error rates were 16.8% (21/125) for Qwen2:72b, 45.6% (57/125) for Llama3.1:70b, and 92.8% (116/125) for Gemma2:27b. The exact agreement between the 2 pathologists across full ranking categories was 76.8% (96/125; Cohen κ=0.668), and agreement on the top-ranked model or tied top group was 81.6% (102/125; Cohen κ=0.722). Conclusions: In this proof-of-concept evaluation, contextual prompting improved ASR transcription accuracy, and Qwen2:72b generated the most accurate English pathology reports among the evaluated LLMs. However, the study used simulated audio recordings, a local vocabulary prompt, and report-level rather than term-level clinical annotation. LLM-generated reports should therefore be considered draft documentation requiring pathologist verification, and prospective validation in real clinical workflows is needed before clinical deployment.

5 June 2026 in JMIR Medical Informatics
Verified
Journal Article
Open access
TCTz-Heng Chen
Tz-Heng Chen
KLKuan-Hsun Lin
Kuan-Hsun Lin
YHYang Ho
Yang Ho
WTWei-Cheng Tseng
Wei-Cheng Tseng
YCYuan-chia Chu
Yuan-chia Chu
DTDer-Cherng Tarng
Der-Cherng Tarng
Background: Chronic kidney disease (CKD) is a global health burden characterized by heterogeneous progression trajectories. Without timely and appropriate management, CKD can lead to increased morbidity and mortality and a reduced quality of life. Therefore, early identification of patients at high risk of developing end-stage renal disease (ESRD) or mortality is essential to facilitate timely intervention and improve patient outcomes. Objective: This study aimed to develop and validate machine learning models to predict ESRD and all-cause mortality in patients with CKD. Methods: We developed and validated machine learning models using data from patients with CKD and an estimated glomerular filtration rate of <60 mL/min/1.73 m 2 , who were treated at Taipei Veterans General Hospital between 2011 and 2021. Predictors included 69 routinely available demographic, clinical, medication, laboratory, and echocardiographic variables. The outcomes were ESRD and all-cause mortality. The cohort was randomly divided into training (n=23,741, 80%) and testing (n=5936, 20%) sets. The evaluated models included extreme gradient boosting, light gradient boosting machine, categorical boosting, random forest, and a stacking classifier. Model performance was assessed using the area under the receiver operating characteristic curve (AUROC), the area under the precision-recall curve, calibration, and decision-curve analysis. Supplementary time-to-event analyses were performed using the kidney failure risk equation and survival-based machine learning models. Results: A total of 29,677 patients were included in the study. The median age was 79 (IQR 70.0‐88.0) years, and 16,359 (55.1%) were male. Among these patients, 14,993 (50.5%) had hypertension, 7908 (26.6%) had diabetes mellitus, and 1768 (6%) had cancer. During follow-up, 649 patients (2.2%) developed ESRD and 3631 (12.2%) died. The models demonstrated high predictive performance for ESRD, with AUROCs ranging from 0.839 to 0.894. For all-cause mortality, the predictive performance was more modest, with AUROCs ranging from 0.752 to 0.774. Given the low incidence of ESRD in this cohort, model performance was additionally evaluated using precision-recall curves. The area under the precision-recall curve ranged from 0.172 to 0.216 for ESRD prediction and from 0.330 to 0.356 for all-cause mortality across models. Calibration and decision-curve analyses supported model reliability and clinical utility. Conclusions: Machine learning algorithms may serve as useful tools for risk stratification of ESRD and all-cause mortality in patients with CKD, with the potential to support more individualized clinical management.